v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 40,237 $ 31,641
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 50,673 69,671
Amortization of deferred financing costs 1,497 1,453
Credit loss expense 23  
Deferred income tax expense (benefit) 2,927 (2,918)
Equity-based employee and director compensation expense 1,102 1,353
Gain on dispositions and lease terminations, net (9,618) (40,789)
Changes in operating assets and liabilities, net of acquisitions (1,268) 1,654
Net cash provided by operating activities 85,573 62,065
Cash flows from investing activities:    
Principal payments received on notes receivable 146 92
Proceeds from sale of assets 26,768 94,788
Capital expenditures (18,056) (28,657)
Cash paid in connection with acquisitions, net of cash acquired (1,800)  
Net cash provided by investing activities 7,058 66,223
Cash flows from financing activities:    
Borrowings under the Credit Facility 78,000 49,000
Repayments on the Credit Facility (95,796) (111,000)
Payments of finance lease obligations (2,829) (2,430)
Payments of deferred financing costs (5,500)  
Distributions paid on distribution equivalent rights (208) (218)
Distributions paid to preferred membership interests (1,512) (1,261)
Distributions paid on common units (60,093) (59,994)
Net cash used in financing activities (87,938) (125,903)
Net increase in cash and cash equivalents 4,693 2,385
Cash and cash equivalents at beginning of period 3,137 3,381
Cash and cash equivalents at end of period $ 7,830 $ 5,766